Back to search

Poland· PL-100221181

Dip Hot Rozgrzewający

A preparations with salicylic acid derivatives product containing methylis salicylas + mentholum + eucalypti aetheroleum + terebinthini aetheroleum, registered in Poland by The Mentholatum Company (Ireland) Ltd.. The same ATC class is registered in 8 of our 19 countries.

ATC M02AC

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedDip Hot RozgrzewającyATCM02ACREGISTER NO.PL-100221181PACKS LISTED4CHECKEDSeptember 27, 2026

Where it is registered

Methylis salicylas + mentholum + eucalypti aetheroleum + terebinthini aetheroleum is registered in 8 of 19 countries.

Countries holding a registration under ATC M02AC (preparations with salicylic acid derivatives), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 5 of them publish a price we can compare per daily dose

Methylis salicylas + mentholum + eucalypti aetheroleum + terebinthini aetheroleum · ATC M02AC

8 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Finlandprice
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Methylis salicylas + Mentholum + Eucalypti aetheroleum + Terebinthini aetheroleum
Manufacturer
The Mentholatum Company (Ireland) Ltd.
Country
Poland (PL)
ATC code
M02AC
ATC class
Preparations with salicylic acid derivatives
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 4

  • gtin
    05909990125319
  • gtin
    05909990125326
  • gtin
    05909990125333
  • gtin
    05909990125340

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/40d78efe-bf03-47fb-bbf8-605a70df3f91
GET /v1/drugs/40d78efe-bf03-47fb-bbf8-605a70df3f91?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Krem",
  "source": "urpl",
  "strength": "(128 mg + 59,1 mg + 19,7 mg + 14,7 mg)/g",
  "packaging": "05909990125319 ¦ OTC ¦ 1368\n1 op. 35 g\n05909990125326 ¦ OTC ¦ 1369\n1 op. 67 g\n05909990125333 ¦ OTC ¦ 47358\n1 op. 100 g\n05909990125340 ¦ OTC ¦ 47359\n1 op. 15 g",
  "substance": "metylu salicylan 128 mg/g + Mentholum 59,1 mg/g + Olejek eukaliptusowy 19,7 mg/g + Olejek terpentynowy 14,7 mg/g + Terebinthini aetheroleum ab  pinum pinastrum 1.47 % + Mentholum 5.91 % + Eucalypti aetheroleum 1.97 % + Methylis salicylas 12.8 %",
  "common_name": "Methylis salicylas + Mentholum + Eucalypti aetheroleum + Terebinthini aetheroleum",
  "pl_product_id": "100221181",
  "pozwolenie_nr": "01253",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about methylis salicylas + mentholum + eucalypti aetheroleum + terebinthini aetheroleum.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.